
Welcome to the investor relations site for Petragen, Inc.
This is a private access area for information that is shared with our investors and partners. Information in the section of our website should be treated as confidential and not shared with others unless explicit written approval is obtained from the company. This is for the benefit of the company, its shareholders and partners. The biotechnology industry is highly competitive and if such information were to be shared with others outside of those that have been given specific access by Petragen, Inc., the consequences could be detrimental to the success of the company.
Recent Events
Past Events
Petragen signs exclusive license with Yale University and NIH for the use of ENPP1 inhibitors in periodontal disease
Petragen closes on its first $1 million financing